Wednesday, June 14, 2017 9:49:09 PM
AusCann is delighted to announce the appointment of prominent Canadian doctor and medical cannabis expert Dr Danial Schecter as its Chief Medical Advisor.
Dr Schecter brings comprehensive knowledge of medical cannabis in practical clinical use. He has worked extensively within the field, having founded the largest referral only clinic in Canada that specialises in cannabinoid medicine.
Doctor training and awareness forms a key part of the Company’s strategy to educate the medical community on the potential benefits of cannabinoids as therapeutic agents to treat certain conditions, such as chronic pain and Dr Schecter will provide clinical guidance, support and education to the doctor community.
AusCann and Dr Schecter recently hosted a number of educational seminars in Sydney Brisbane and Perth as part of its Medical Outreach Program, which received an overwhelmingly positive response from Australian doctors.
FEATURED Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • Apr 17, 2024 8:00 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM
Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM